You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
|
---|---|
Published in |
Cochrane database of systematic reviews, August 2012
|
DOI | 10.1002/14651858.cd003915.pub4 |
Pubmed ID | |
Authors |
Claire L Vale, Jayne Tierney, Sarah J Bull, Paul R Symonds |
Abstract |
Although endometrial adenocarcinoma is a common gynaecological cancer, a comparatively small proportion of patients present with, or develop, recurrent or advanced disease. However, for those women whose disease does progress or recur the prognosis is poor and the best treatment is yet to be identified. Co-morbidity, including obesity and cardiac disease, and concerns over toxicity have prevented more extensive studies of cytotoxic chemotherapy, although there are a number of active agents. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 50% |
United States | 1 | 25% |
Unknown | 1 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 183 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 181 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 30 | 16% |
Researcher | 24 | 13% |
Student > Bachelor | 17 | 9% |
Other | 14 | 8% |
Unspecified | 12 | 7% |
Other | 41 | 22% |
Unknown | 45 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 68 | 37% |
Nursing and Health Professions | 17 | 9% |
Unspecified | 12 | 7% |
Biochemistry, Genetics and Molecular Biology | 9 | 5% |
Psychology | 6 | 3% |
Other | 21 | 11% |
Unknown | 50 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 August 2022.
All research outputs
#4,680,622
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#6,822
of 11,499 outputs
Outputs of similar age
#32,498
of 186,216 outputs
Outputs of similar age from Cochrane database of systematic reviews
#114
of 207 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 186,216 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 207 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.